tm logo

Monitor this mark

View On USPTO

ZIMRIXBY
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 11 Jul 2024

Last Applicant/ Owned by

Fresenius Kabi Deutschland GmbH

Else-Kroener-Str. 1

Bad Homburg

DE

61352

Serial Number

97542559 filed on 10th Aug 2022

Registration Number

N/A

Correspondent Address

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

WASHINGTON, DC 20007

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ZIMRIXBY

Pharmaceutical preparations for human use for the treatment of immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment of immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97542559

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 034175.093

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
24th Jul 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11th Jul 2024SOU EXTENSION 2 FILED
11th Jul 2024SOU EXTENSION 2 GRANTED
11th Jul 2024SOU TEAS EXTENSION RECEIVED
16th Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Jan 2024SOU EXTENSION 1 GRANTED
14th Jan 2024SOU EXTENSION 1 FILED
14th Jan 2024SOU TEAS EXTENSION RECEIVED
22nd Aug 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27th Jun 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED